BT Lab
SKU(재고 관리 코드):E7144Hu
Human Soluble Suppression of Tumorigenicty 2,SST2 ELISA kit
Human Soluble Suppression of Tumorigenicty 2,SST2 ELISA kit
Contact us for 48 wells and bulk quote
Introducing the Human Soluble Suppression of Tumorigenicity 2 (SST2) ELISA kit, a cutting-edge solution designed to accurately measure the levels of SST2 in human samples. This advanced assay kit is meticulously developed to provide researchers and clinicians with a reliable tool for investigating the role of SST2 in tumorigenesis.
The Human SST2 ELISA kit employs a highly sensitive enzyme-linked immunosorbent assay technique, enabling precise quantification of SST2 in a wide range of biological specimens. With its exceptional specificity and accuracy, this kit ensures robust and reproducible results, facilitating comprehensive analysis of SST2 expression and its potential implications in cancer development.
Crafted with utmost precision, the Human SST2 ELISA kit offers a user-friendly workflow, allowing for seamless execution of experiments. The kit includes all necessary components, meticulously optimized to ensure optimal performance and minimize experimental variability. Its comprehensive instructions provide clear guidance, enabling researchers to effortlessly perform the assay with minimal technical expertise.
This innovative kit is designed to meet the demands of both basic research and clinical applications. By accurately measuring SST2 levels, researchers can gain valuable insights into its potential as a biomarker for tumorigenesis. Moreover, clinicians can utilize this kit to monitor SST2 expression in patients, aiding in the diagnosis, prognosis, and treatment selection for various cancers.
In summary, the Human Soluble Suppression of Tumorigenicity 2 (SST2) ELISA kit represents a state-of-the-art solution for investigating the role of SST2 in tumorigenesis. With its exceptional sensitivity, specificity, and user-friendly design, this kit empowers researchers and clinicians to delve deeper into the intricate mechanisms underlying cancer development, ultimately paving the way for improved diagnostics and therapeutic interventions.
Share
